Coral Laboratories Limited (BOM:524506)
India · Delayed Price · Currency is INR 650.10
+1.35 (0.21%)
At close: Aug 21, 2026
Coral Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 967.01 | 859 | 1,150 | 836.6 | 781.19 | 756.11 |
Other Revenue | 1.03 | - | - | - | - | - |
| 968.04 | 859 | 1,150 | 836.6 | 781.19 | 756.11 | |
Revenue Growth | -5.25% | -25.31% | 37.47% | 7.09% | 3.32% | -21.70% |
Cost of Revenue | 404.6 | 355.35 | 540.65 | 381.04 | 467.73 | 408.04 |
Gross Profit | 563.44 | 503.65 | 609.4 | 455.57 | 313.46 | 348.07 |
Selling, General & Admin | 167.83 | 159.15 | 151.46 | 121.4 | 112.93 | 117.5 |
Other Operating Expenses | 209.4 | 192.36 | 191.88 | 168.3 | 157.99 | 144.69 |
Operating Expenses | 400.71 | 372.88 | 363.45 | 309.46 | 292.73 | 282.1 |
Operating Income | 162.74 | 130.77 | 245.95 | 146.11 | 20.73 | 65.97 |
Interest Expense | -1.45 | -1.71 | -0.98 | -0 | -3.39 | -1.41 |
Interest & Investment Income | - | - | 48.39 | 33.56 | 17.87 | 17.49 |
Currency Exchange Gain (Loss) | - | - | 14.88 | 9.51 | 32.35 | 13.83 |
Other Non Operating Income (Expenses) | 98.97 | 98.97 | 24.15 | 19.78 | 14.31 | 13.09 |
EBT Excluding Unusual Items | 260.26 | 228.02 | 332.4 | 208.96 | 81.88 | 108.96 |
Other Unusual Items | 3.13 | 3.13 | -7.7 | -1.64 | 0.38 | 9.59 |
Pretax Income | 263.39 | 231.15 | 324.7 | 207.32 | 82.26 | 118.56 |
Income Tax Expense | 71.34 | 67.34 | 83.15 | 49.43 | 17.81 | 28.1 |
Net Income | 192.05 | 163.81 | 241.56 | 157.89 | 64.45 | 90.46 |
Net Income to Common | 192.05 | 163.81 | 241.56 | 157.89 | 64.45 | 90.46 |
Net Income Growth | 7.20% | -32.18% | 52.99% | 144.97% | -28.75% | -33.27% |
Shares Outstanding (Basic) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Outstanding (Diluted) | 4 | 4 | 4 | 4 | 4 | 4 |
Shares Change | 0.02% | 0.01% | - | - | - | - |
EPS (Basic) | 53.75 | 45.85 | 67.61 | 44.19 | 18.04 | 25.32 |
EPS (Diluted) | 53.75 | 45.85 | 67.61 | 44.19 | 18.04 | 25.32 |
EPS Growth | 7.17% | -32.19% | 52.99% | 144.97% | -28.75% | -33.27% |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | -79.16 | -41.67 | -64.56 | 107.2 | 5.35 |
Free Cash Flow Per Share | - | -22.16 | -11.66 | -18.07 | 30.01 | 1.50 |
Dividend Per Share | - | 2.000 | 1.500 | 2.000 | - | - |
Dividend Growth | - | 33.33% | -25.00% | - | - | - |
Gross Margin | 58.20% | 58.63% | 52.99% | 54.45% | 40.13% | 46.03% |
Operating Margin | 16.81% | 15.22% | 21.39% | 17.46% | 2.65% | 8.72% |
Profit Margin | 19.84% | 19.07% | 21.00% | 18.87% | 8.25% | 11.96% |
Free Cash Flow Margin | - | -9.22% | -3.62% | -7.72% | 13.72% | 0.71% |
EBITDA | 184.45 | 152.13 | 265.92 | 165.82 | 42.45 | 85.75 |
EBITDA Margin | 19.05% | 17.71% | 23.12% | 19.82% | 5.43% | 11.34% |
D&A For EBITDA | 21.72 | 21.37 | 19.97 | 19.71 | 21.72 | 19.78 |
EBIT | 162.74 | 130.77 | 245.95 | 146.11 | 20.73 | 65.97 |
EBIT Margin | 16.81% | 15.22% | 21.39% | 17.46% | 2.65% | 8.72% |
Effective Tax Rate | 27.08% | 29.13% | 25.61% | 23.84% | 21.65% | 23.70% |
Revenue as Reported | 1,067 | 957.97 | 1,241 | 902.93 | 850.14 | 804.24 |
Advertising Expenses | - | - | 4.09 | 9.41 | 1.6 | 5.24 |